Jan Petter Larsen

Title: Innovations by Jan Petter Larsen in Parkinson's Disease Research

Introduction

Jan Petter Larsen is an accomplished inventor based in Queens, NY (US), known for his significant contributions to the field of medical research, particularly in the area of Parkinson's disease. With a total of three patents to his name, Larsen has made strides in identifying biomarkers that can aid in the prognosis of this debilitating condition.

Latest Patents

Larsen's latest patents focus on circulating serum microRNA biomarkers and methods for Parkinson's disease prognosis. These inventions provide innovative biomarkers and methods for identifying, verifying, and confirming circulating serum-based microRNAs. The microRNAs, referred to as PrognomiRs, can be utilized to differentiate patients suffering from rapid progressing Parkinson's disease (PD) from those with slow progressing PD. This advancement holds promise for improving patient outcomes through more tailored treatment approaches.

Career Highlights

Larsen's work at St. John's University has positioned him as a key figure in the research community. His dedication to advancing medical science is evident through his innovative patents and ongoing research efforts. His contributions have the potential to significantly impact the understanding and treatment of Parkinson's disease.

Collaborations

Larsen has collaborated with notable colleagues, including Simon Geir Moller and Indranil Basak. These partnerships have fostered a collaborative environment that enhances the research process and leads to groundbreaking discoveries.

Conclusion

Jan Petter Larsen's work in developing microRNA biomarkers for Parkinson's disease prognosis exemplifies the intersection of innovation and medical research. His contributions are paving the way for improved diagnostic methods and treatment strategies for patients affected by this challenging condition.